Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus

Eitemau Tebyg

• Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
  gan: Hemmingsen, Bianca, et al.
  Cyhoeddwyd: (2016)
• Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
  gan: Madsen, Kasper S, et al.
  Cyhoeddwyd: (2019)
• Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
  gan: Kasper Madsen, et al.
  Cyhoeddwyd: (2019)
• Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
  gan: Hemmingsen, Bianca, et al.
  Cyhoeddwyd: (2017)
• Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
  gan: Bianca Hemmingsen, et al.
  Cyhoeddwyd: (2017)